The Spanish Agency for Medicines and Health Products (AEMPS) has launched a health alert . In this case, a batch of medications against infection of urine .
Specifically, it is some capsules against urine infection of the brand Ellure . This medicine comes from a French laboratory and has been disseminated and distributed throughout Spain .
For the sake of our health, the AEMPS releases this health alert as one of the first notices of the year. The objective is that these capsules of French origin are withdrawn from the market as soon as possible.
The Ellura hard capsules incorporate in each of their boxes with 15 capsules. The drug is intended for those who have problems with their urological system when going to the bathroom .
The Spanish Agency for Medicines and Health Products (AEMPS) presents it with its file accompanied by its trademark, presentation, registration number and national code.
- In that sense, and for more signs for those who have been affected or have this medicine in their pantries, it is clarified that the registration number is 82692 and the national code is 720015.
- Likewise, the Official Spanish Denomination reflects that it comes from the purified cranberry, dry extract, due to its natural origin.
- The specific batch of drugs that raises the alert is NO 205802 and expires on 31 August 2023.
- The laboratory from which this medicine has come is Laboratoire Pharmaceutique Pharmatoka, SAS – 15 – 22, Avenue de la Republique, Rueil-Malmaison, 92500, France.
However, it has two different manufacturers at very distant points from each other. On the one hand, there is Suheung 683 Yeonje-ri, Osong-eup, Cheongwon-gun, Chungbuk, based in Seoul, Korea.
Then, in Switzerland, Soho Flordis International Switzerland, S.A. also manufactures these drugs. – Via Mulini, Bioggio, 6934.
This is a traditional medicine that is made based on plants, with the dry extraction of cranberries.
It is also used to prevent the recurrence of uncomplicated acute infections of the lower urinary tract, that is, cystitis.